Elhízás: vizsgálatok itt: Németország
86 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in NémetországA Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER‑OSA 1)
- Where
- Bamberg, Bochum, Duesseldorf, Hamburg, Hanover, Ibbenbüren, Karlsruhe, Oldenburg in Holstein, Schleswig
- Életkor
- 18 év and over
- People
- 30
- Run by
- Pfizer Inc.
See details and how to join2026-526327-22-00 · EU 2026-526327-22-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Hamburg, Hof, Köln, Munich, Münster, Pirna
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Bad Oeynhausen, Erlangen, Essen, Frankfurt Am Main, Gelnhausen, Hamburg, Hof, Köln, Münster, Pirna
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - No phaseNot yet taking people in NémetországExercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
- Where
- Düsseldorf
- Életkor
- 18 év and over
- People
- 94
- Run by
- German Diabetes Center
See details and how to joinNCT07926152 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Bad Oeynhausen, Luebeck, Oldenburg in Holstein, Schwerin
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Berlin, Bochum, Hanover, Hohenmölsen, Karlsruhe, Leipzig, Obertshausen, Offenbach Am Main, Oldenburg in Holstein, Ratingen
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 3. fázisNot yet taking people in NémetországA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Berlin, Duisburg, Elsterwerda, Frankfurt, Hamburg, Münster, Oldenburg in Holstein
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 2. fázisTaking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Essen, Leipzig, Muenster, Oldenburg in Holstein
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Berlin, Bünde, Essen, Hamburg, Muenster, Münster, Oldenburg in Holstein
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Bochum, Buende, Duisburg, Hamburg, Karlsruhe, Leipzig, München, Offenbach Am Main
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Bamberg, Berlin, Essen, Hanover, Karlsruhe, Marburg, Oldenburg, Schwerin
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Duisburg, Hamburg, Münster, Offenbach, Oldenburg
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 3. fázisNot yet taking people in NémetországA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Berlin, Bochum, Cologne, Essen, Gladbeck, Hamburg, Leipzig, Lübeck, Offenbach, Oldenburg, Ratingen
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisNot yet taking people in NémetországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Berlin, Bochum, Elsterwerda, Frankfurt am Main, Lübeck, Mannheim, Offenbach Am Main, Oldenburg in Holstein, Pohlheim, Stuttgart, Villingen-Schwenningen, Weinheim
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- Berlin, Essen, Hamburg, Hanover, Karlsruhe, Oldenburg in Holstein
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 · EU 2025-522699-94-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Munich, Offenbach Am Main, Schwerin, Speyer, Wiesbaden, Zwenkau
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisNot yet taking people in NémetországELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
- Where
- Bad Homburg, Erlangen, Freiburg im Breisgau, Leipzig, Mainz
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
- Where
- Berlin, Essen, Hanover, Leipzig
- Életkor
- 18 év and over
- People
- 932 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bad Berka, Bad Neustadt an der Saale, Bad Segeberg, Berlin, Bonn, Detmold, Dortmund, Dresden, Düsseldorf, Frankfurt am Main, Fulda, Göttingen, Hamburg, Haßloch, Heidelberg, Homburg, Jena, Kaiserslautern, Leipzig, Leverkusen, Mainz, Mannheim, Minden, München, Offenbach, Papenburg, Regensburg, Schwäbisch Hall, Siegen, Ulm, Wermsdorf
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Berlin, Bochum, Bünde, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bad Berka, Bad Neustadt A.D.Saale, Bad Segeberg, Berlin, Bonn, Detmold, Dortmund, Dresden, Duesseldorf, Frankfurt am Main, Frankfurt Am Main, Fulda, Goettingen, Hamburg, Hassloch, Heidelberg, Homburg, Jena, Kaiserslautern, Leipzig, Leverkusen, Mainz, Mannheim, Minden, Munich, Offenbach Am Main, Papenburg, Regensburg, Schwäbisch Hall, Siegen, Ulm, Wermsdorf
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisNot yet taking people in NémetországEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
- Where
- Berlin, Bochum, Cologne, Dresden, Fulda, Hamburg, Hanover, Karlsruhe, Leipzig, Muenster, Munich, Naunhof, Oldenburg in Holstein, Pirna, Witten
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00 - 3. fázisTaking peopleA Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- Where
- Ulm
- Életkor
- 2 év and over
- People
- 4 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07220772 · EU 2024-518674-14-00